Member Info for PM2022

After dilution 1.8 million market vs 1.6 million cash leaving asset value 200k.

CLX is worth almost zero, 401 and 201 deals at zero and lab the same even though he had decent contracts recently.

Surely with cash and some news we will eventually hit the 1.5-2.0p mark as a minimum.

It doesn't work that way. Most of the costs will go towards R and D.

It can take millions to get a drug through preclinical. The more that comes through the more funding you need, the higher the cash burn and the quicker the cash runs out.

Yeah but it never happened before the placing so now you have to judge it as it is.

Answer the questions rather than trying to hide it?

You have to look at the situation as it is. The hope was 401 would complete or even 201. The result is a tiny market cap but with 100s of millions of more shares plus more warrants.

More projects into the preclinical stage will almost certainly happen in the next few months as stated in the RNS. Who will pay to fund those projects through preclinical?

If the market cap was 5,10,20,30 ,50 million like previous years then funding 2/3/4 million is not really an issue and an amazing investment but this has gone the other way. Low market cap cash burn getting out of control with more projects and more and more shares.

I don't even think they have done the real pre-clinical testing for CLX yet, toxicology testing which is expensive etc it seems they are still trying to work out the correct formulation etc?

CLX is miles away. Not sure where this is going as more projects will come into the preclinical stage. Market cap 1 million odd and cash burn goes to 3 million, 5 million plus if 2 more go through yet CLX is miles away so how will the company survive? That is my real concern but I would like the company to do well but sadly this is a disaster.

Just being realistic not negative or even positive. I lost count of how much shares we will have if these warrants are executed but another placing would likely also be between 0.1p and 2p so another 500 million to 2 billion shares. That is 1 placing away so obviously. Where would that put the share price so they would likely consolidate in the next 2 years.

The strategy is good but it is also flawed. They will keep bringing projects in but the problem will be when it passes the evaluation stage you then have to invest millions on the next project that goes into pre-clinical that will increase the cash burn.

People do not realise the cash burn here is likely to be in excess of 3/4 million or more once the next project comes through just like investing for CLX and the cycle carries on. 3 then 4 then 5 in preclinical cash burn 10 million etc. The only real hope is if CLX can strike a deal in the next 18 months.

I said it before no more funding for new projects unless CLX is a failure. They need a real deal first otherwise this will eventually end up the same as 4D as cash burn will be out of control funding new expensive pre clinical projects costing millions for each one.

Don't be surprised. The largest gains for BOD and others would be buying into the placing with warrants and possibly releasing options and then releasing the news even if it just went to 2p that would be more than enough for them. I think it is independent and I would say it is 5050 in regards to 201 as little is known.

Longer term we will likely see another consolidation but that could be another placing or two away. I never thought it would happen again but it seems likely in the next 2/3 years given the warrants and placing price unless CLX gets a deal.

In this market it is better to trade and look for daily news with large returns and not attach to a single stock. I got about 8/10 correct recently in the likes of FAR, Mkongo etc as long as you can understand market caps and the value of big news. Keeping hold of stocks with lower market caps than what they should be and high dilutions means large losses.

I think this will move to 0.60/0.70 then it remains to be seen whether either 201 or 401 comes good. if it does we can look at 1.5p/2p if not then another placing will likely be at 0.10p next time.

Valirx will eventually deliver but that could be 0.1p to 0.3p or maybe 0.60p to 2p or even 0.01p to 0.04p.

Likely it goes down to 0.5p/0.6p before it goes up again given the placing shares are to be released.

No, not wrong. The ones that were wrong were the ones that backed the resolutions. In the end it will mainly be the BOD that will make the money here. Wait for the options to come out.

It was hardly much of a prediction that they were out of funds. Chances of 201 coming good first this time were very low.

The current market cap is way below fair value. Self funded, valuable assets and no placing.

Outlook

As previously highlighted, the Company is well positioned to generate increasing levels of revenue from the CEA and PFP divisions, building on the strong progress achieved during the Period. This is expected to further enhance Group margins and is part of the previously highlighted rebalancing of the portfolio and sales mix.

With increased visibility across PFP and CEA and a strong and growing quoted pipeline - valued at over £50m, the focus remains on increased levels of conversion, as the Group trends towards profitability.

As such, management is confident that the business remains well placed to achieve continued growth and its objectives of net profitability and being operationally self-funded.

· The Project is estimated to generate a total of US$9 billion in gross revenues, US$4.9 billion in net operating profit and US$4.6 billion in free cash flow over its 15-year mine life.

Surely this should at least double in the coming days. A good entry point IMO. The only way is up IMO.

Strange time to go on holiday given the position this is in if it is true. I wonder if it has anything to do with signing 201 and closing the deal as I find it hard to see how he could go on holiday until the cash situation is resolved.

Unless it is upfront, it will not make much difference if they burn about 500k a month but it might help with the next placing. Yes it has potential but feel in the short term we are likely to see this drift ahead of the placing.

I hope I am wrong and I would be very happy to see us rise but the short term issues and very high cash burn is really concerning until significant revenues are announced.

The problem is I think they might need to raise about 10 million pounds or more in the next fundaise.

Surely then it will need to offer a significant discount and in my view this likely keep drifting until then. I am happy to wait for the 0.5p range and see where we are.

Revenue will take time, profit will take time. Meanwhile, huge costs and a placing likely early 2025 to cover the huge monthly cash burn.

Try raising 8 million in this market , not easy. My target remains 0.5p buy in.

Yeah and he will buy maybe another 30 million. They still need cash and lots of it.

Not saying no potential but the timing is not great. Will wait few weeks until after the placing. Many thanks mayne buy at 0.5p.

Do the maths. Cash burn will go even higher soon so we are looking at about 4 months. Large amount to raise so would expect a drift. Unlikely placing would be done last minute.